✦ LIBER ✦

0159 Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozole

✍ Scribed by T. Safra; R. Bernstein Molho; I. Stephansky; N. Yaal-Hahoshen; M. Inbar; A. Ackerstein; D. Geffen

Book ID: 114316296
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 53 KB
Volume: 18
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(09)70190-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

Zoledronic Acid Inhibits Adjuvant Letroz

Zoledronic Acid Inhibits Adjuvant Letrozole-Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

✍ Brufsky, Adam (author);Harker, W. Graydon (author);Beck, J. Thaddeus (author);Ca 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 176 KB

4–49 Zoledronic Acid Inhibits Adjuvant L

4–49 Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The Protective Effect of Zoledronic Acid

The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial

✍ Safra, Tamar; Bernstein-Molho, Rinat; Greenberg, Julia; Pelles-Avraham, Sharon; 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 317 KB

Immediate versus delayed zoledronic acid

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

✍ Stephanie L. Hines; Betty Mincey; Todor Dentchev; Jeff A. Sloan; Edith A. Perez; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 190 KB

Effective inhibition of aromatase inhibi

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole : ZO-FAST study results

✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the